{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:22:13Z","timestamp":1777476133704,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010573","name":"Dioraphte Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-01251"],"award-info":[{"award-number":["2022-01251"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"publisher","award":["MR\/P027989\/1"],"award-info":[{"award-number":["MR\/P027989\/1"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jchromb.2025.124652","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T06:44:28Z","timestamp":1747291468000},"page":"124652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quantitative analysis of DNDI-6174 using UPLC-MS\/MS: A preclinical target site pharmacokinetic study"],"prefix":"10.1016","volume":"1262","author":[{"given":"Wietse M.","family":"Schouten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrien","family":"Van Bocxlaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde","family":"Rosing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alwin D.R.","family":"Huitema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos H.","family":"Beijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jadel M.","family":"Kratz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"Mowbray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.C.","family":"Dorlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2025.124652_bb0005","author":"World Health Organization (WHO)"},{"key":"10.1016\/j.jchromb.2025.124652_bb0010","series-title":"Global leishmaniasis surveillance, updates 2023: 3 years of the NTD road map","author":"World Health Organization (WHO)","year":"2024"},{"key":"10.1016\/j.jchromb.2025.124652_bb0015","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy\u2014challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jchromb.2025.124652_bb0020","series-title":"Drug Discovery for Leishmaniasis","first-page":"24","article-title":"Chapter 2: Anti-leishmanial drug discovery: Past, present and future perspectives","author":"Mowbray","year":"2018"},{"key":"10.1016\/j.jchromb.2025.124652_bb0025","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/cid\/ciw742","article-title":"Diagnosis and treatment of Leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jchromb.2025.124652_bb0030","first-page":"111","article-title":"Drug resistance in Leishmaniasis, journal of global","volume":"2","author":"Chakravarty","year":"2010","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.jchromb.2025.124652_bb0035","author":"Drugs for Neglected Disease initiative (DNDi)"},{"key":"10.1016\/j.jchromb.2025.124652_bb0040","doi-asserted-by":"crossref","first-page":"eadh9902","DOI":"10.1126\/scitranslmed.adh9902","article-title":"DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc(1)","volume":"15","author":"Braillard","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jchromb.2025.124652_bb0045","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1038\/srep08771","article-title":"New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource","volume":"5","author":"Pe\u00f1a","year":"2015","journal-title":"Sci. Report."},{"key":"10.1016\/j.jchromb.2025.124652_bb0050","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/AAC.00850-16","article-title":"Targeting the cytochrome bc1 complex of Leishmania parasites for discovery of novel drugs","volume":"60","author":"Ortiz","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2025.124652_bb0055","first-page":"1573","article-title":"Targeting the mitochondrial Electron transport chain of plasmodium falciparum: new strategies towards the development of improved Antimalarials for the elimination era, future","volume":"5","author":"Nixon","year":"2013","journal-title":"Med. Chem."},{"key":"10.1016\/j.jchromb.2025.124652_bb0060","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.jchromb.2025.124652_bb0065","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.4155\/bio.12.252","article-title":"Bioanalysis of drug in tissue: current status and challenges","volume":"4","author":"Xue","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2025.124652_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113590","article-title":"Skin tissue sample collection, sample homogenization, and analyte extraction strategies for liquid chromatographic mass spectrometry quantification of pharmaceutical compounds","volume":"191","author":"Roseboom","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124652_bb0075","series-title":"Tissue Sample Preparation in LC-MS Bioanalysis, Sample Preparation in LC-MS Bioanalysis","first-page":"201","author":"Gao","year":"2019"},{"key":"10.1016\/j.jchromb.2025.124652_bb0080","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4155\/bio.14.34","article-title":"Recommendations from the European bioanalysis forum on method establishment for tissue homogenates","volume":"6","author":"Timmerman","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2025.124652_bb0085","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1016\/j.jpba.2021.114402","article-title":"Development and validation of an HPLC-MS\/MS method for the quantification of the anti-leishmanial drug miltefosine in human skin tissue","volume":"207","author":"Roseboom","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124652_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123494","article-title":"Development and validation of an ultra-high performance liquid chromatography coupled to tandem mass spectrometry method for the quantification of the antileishmanial drug paromomycin in human skin tissue","volume":"1211","author":"Roseboom","year":"2022","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2025.124652_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123354","article-title":"Development and validation of a high-performance liquid chromatography tandem mass spectrometry method for the quantification of the antiparasitic and antifungal drug amphotericin B in human skin tissue","volume":"1206","author":"Roseboom","year":"2022","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2025.124652_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124377","article-title":"Development and validation of ultra-performance liquid chromatography tandem mass spectrometry methods for the quantitative analysis of the antiparasitic drug DNDI-6148 in human plasma and various mouse biomatrices","volume":"1250","author":"Schouten","year":"2025","journal-title":"J. Chromatogr. B"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225002065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225002065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T20:29:39Z","timestamp":1748982579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023225002065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":20,"alternative-id":["S1570023225002065"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124652","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative analysis of DNDI-6174 using UPLC-MS\/MS: A preclinical target site pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"124652"}}